The Renal Tubule in the Progression of Chronic Renal Failure

Journal of Investigative Medicine

Volumn 45, Issue 6, 1997, Pages 346-361

  Palmer, Biff F ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANIMAL; CHRONIC KIDNEY FAILURE; FIBROSIS; HUMAN; KIDNEY TUBULE; PATHOLOGY; PHYSIOLOGY; PROTEIN INTAKE; PROTEINURIA; REVIEW;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; DIETARY PROTEINS; FIBROSIS; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TUBULES; PROTEINURIA;

EID: 0031201935     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (172)

1. Risdon RA, Sloper JC, De Wardener H. Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis. Lancet 1968;2:363-6.
2. Schainuck LI, Striker GE, Cutler RE, Benditt EP. Structural-functional correlations in renal disease. Hum Pathol 1970;1:631-41.
3. Bohle A, Muller GA, Wehrmann M, Mackensen-Haen S, Xiao J. Pathogenesis of chronic renal failure in the primary glomerulopathies, renal vasculopathies, and chronic interstitial nephritides. Kidney Int 1996;49 (54 Suppl):S2-9.
4. Schmitt H, Bohle A, Reineke T, Mayer-Eichberger D, Vogl W. Long-term prognosis of membranoproliferative glomerulonephritis type I. Nephron 1990;55:242-50.
5. Wehrmann M, Bohle A, Bogenschutz O, Eissele R, Freislederer A, Ohlschlegel C, Schumm G, Batz C, Gartner H. Long-term prognosis of chronic idiopathic membranous glomerulonephritis. Clin Nephrol 1989;31:67-76.
6. Wehrmann M, Bohle A, Held H, Schumm G, Kendziorra H, Pressler H. Long-term prognosis of focal sclerosing glomerulonephritis. An analysis of 250 cases with particular regard to tubulointerstitial changes. Clin Nephrol 1990;33:115-22.
7. Abe S, Amagasaki Y, Iyori S, Konishi K, Kato E, Sakaguchi H. Significance of tubulointerstitial lesions In biopsy specimens of glomerulonephritis patients. Am J Nephrol 1989;9:30-7.
8. Bohle A, Wehrmann M, Bogenschutz O, Batz C, Muller CA. The pathogenesis of chronic renal failure in diabetic nephropathy. Path Res Pract 1991;187:251-9.
9. D'Amico G. Influence of clinical and histological features on actuarial renal survival in adult patients with idiopathic IgA nephropathy, membranous nephropathy, and membranoproliferative glomerulonephritis: survey of the recent literature. Am J Kidney Dis 1992;20:315-23.
10. Okuda S, Languino LR, Ruoslahti E, Border WA. Elevated expression of transforming growth factor-α and pProteoglycan pProduction in experimental glomerulonephritis. J Clin Invest 1990;86:453-62.
11. Yamamoto T, Noble NA, Miller DE, Border WA. Sustained expression of TGF-β1 underlies development of progressive kidney fibrosis. Kidney Int 1994;45:916-27.
12. Bertani T, Cutillo F, Zoja C, Broggini M, Remuzzi G. Tubulointerstitial lesions mediate renal damage in adriamycin glomerulopathy. Kidney Int 1986;30:488-96.
13. Anderson S, Diamond JR, Karnovsky MJ, Brenner BM. Mechanisms underlying transition from acute glomerular injury to late glomerular sclerosis in a rat model of nephrotic syndrome. J Clin Invest 1988;82:1757-68.
14. D-Amico G, Ferrario F, Rastaldi MP. Tubulointerstitial damage in glomerular diseases: its role in the progression of renal damage. Am J Kidney Dis 1995;26:124-32.
15. Stein-Oakley AN, Maguire JA, Dowling J, Perry G, Thomson NM. Altered expression of fibrogenic growth factors in IgA nephropathy and focal and segmental glomerulosclerosis. Kidney Int 1997;51:195-204.
16. Hooke DH, Gee DC, Atkins RC. Leukocyte analysis using monoclonal antibodies in human glomerulonephritis. Kidney Int 1987;31:964-72.
17. Brunati C, Brando B, Confalonieri R, Belli LS, Lavagni MG, Minetti L. Immunophenotyping of mononuclear cell infiltrates associated with renal disease. Clin Nephrol 1986;26:15-20.
18. Boucher A, Droz D, Adafer E, Noel L. Characterization of mononuclear cell subsets in renal cellular interstitial infiltrates. Kidney Int 1986;29:1043-9.
19. Kliem V, Johnson RJ, Alpers CE, Yoshimura A, Couser WG, Koch KM, Floege J. Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats. Kidney Int 1996;49:666-78.
20. Diamond JR, Kees-Folts D, Ding G, Frye JE, Restrepo NC. Macrophages, monocyte chemattractant peptide-1, and TGF-β1 in experimental hydronephrosis. Am J Physiol 1994;266:F926-33.
21. Johnson RJ, Alpers CE, Yoshimura A, Lombardi D, Pritzl P, Floege J, Schwartz S. Renal injury from angioensin II-mediated hypertension. Hypertension 1992;19:464-74.
22. Alexopoulos E, Seron D, Hartley RB, Nolasco F, Cameron S. Immune mechanisms in idiopathic membranous nephropathy: the role of the interstitial infiltrates. Am J Kidney Dis 1989;13:404-12.
23. Alexopoulos E, Seron D, Hartley RB, Cameron JS: Lupus Nephritis. Correlation of interstitial cells with glomerular function. Kidney Int 1990;37:100-9.
24. Schmouder RL, Strieter RM, Kunkel SL. Interferon-gama regulation of human renal cortical epithelial cell derived monocyte chemotactic peptide-1. Kidney Int 1993;44:43-9.
25. Taub DD, Proost P, Murphy WJ, Anver M, Longo DL, Van Damme J, Oppenheim JJ. Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T Lymphocytes. J Clin Invest 1995;95:1370-6.
26. Jiang Y, Beller DI, Frendl G, Graves DT. Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. J Immunol 1992;148:2423-8.
27. Prodjosudjadi W, Gerritsma JSJ, Klar-Mohamad N, Gerritsen AF, Bruijn JA, Daha MR, Van es LA. Production and cytokine-mediated regulation of monocyte chemoattractant protein-1 by human proximal tubular epithelial cells. Kidney Int 1995;48:1477-86.
28. Grandaliano G, Gesualdo L, Ranieri E, Monno R, Montinaro V, Marra G, Schena FP. Monocyte chemotactic peptide-1 expression in acute and chronic human nephritides: a pathogenetic role in interstitial monocyte recruitment. J Am Soc Nephrol 1996;7:906-13.
29. Eddy AA, Giachelli CM. Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria. Kidney Int 1995;47:1546-57.
30. Pichler R, Giachelli CM, Lombardi D, Pippin J, Gordon K, Alpers CE, Schwartz SM, Johnson RJ. Tubulointerstitial fisease in glomerulonephritis. potential role of osteopontin (Uropontin). Am J Pathol 1994;144:915-26.
31. Giachelli CM, Pichler R, Lombardi D, Denhardt DT, Alpers CE, Schwartz SM, Johnson RJ. Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis. Kidney Int 1994;45:515-24.
32. Barisoni L, Radhakrishman J, D'Agati V. Osteopontin mRNA and protein expression in glomerular disease correlates with tubulointerstitial damage. J Am Soc Nephrol 1996;7:1751A.
33. Kees-Folts D, Sadow JL, Schreiner GF. Tubular catabolism of albumin is associated with the release of an antiinflammatory lipid. Kidney Int 1994;45:1697-709.
34. Zoja C, Morigi M, Figliuzzi M, Bruzzi I, Oldroyd S, Benigni A, Ronco P, Remuzzi G. Proximal tubular cell synthesis and secretion of endothelin-1 on challenge with albumin and other proteins. Am J Kidney Dis 1995;26:934-41.
35. Heeger P, Wolf G, Meyers C, Sun MJ, O'Farrell SC, Krensky AM, Neilson EG. Isolation and characterization of cDNA from renal tubular epithelium encoding murine rantes. Kidney Int 1992;41:220-5.
36. Frank J, Engler-Blum G, Rodemann H, Muller GA. Human renal tubular as a cytokine source. PDGF-β, GM-CSF, and IL-6 mRNA expression in vitro. Exp Nephrol 1993;1:26-35.
37. Burton CJ, Walls J. Proximal tubular cell, proteinuria and tubulointerstitial scarring. Nephron 1994;68:287-93.
38. Ong ACM, Jowett TP, Moorhead JF, Owen JS. Human high density lipoproteins stimulate endothelin-1 release by cultured human renal proximal tubular cells. Kidney Int 1994;46:1315-21.
39. Hanggono T, Rao GS. Chemotaxis of human blood monocytes toward endothelin-1 and the influence of calcium channel blockers. Biochem & Biophys Res Comm 1992;189:994-1000.
40. Benigni A, Remuzzi G. Glomerular protein trafficking and progression of renal disease to terminal uremia. Semin Nephrol 996;16:151-9.
41. Orisio S, Benigni A, Bruzzi I, Corna D, Perico N, Zoja C, Benatti L, Remuzzi G. Renal endothelin gene expression is increased in remnant kidney snd correlates with disease progression. Kidney Int 1993;43:354-8.
42. Zoja C Corna D, Bruzzi I, Foglierri C, Bertani T, Remuzzi G, Benigni A. Passive Heymann nephritis: evidence that angiotensin converting enzyme inhibition reduces proteinuria and retards renal structural injury. Exp Nephrol 1996;4:213-21.
43. Eddy AA. Protein restriction reduces transforming growth factor-β and interstitial fibrosis in nephrotic dyndrome. Amer J Physiol 1994;266:F884-93.
44. Jevnikar AM, Brennan DC, Singer GG, Heng JE, Maslinski W, Wuthrich RP, Glimcher LH, Kelley VER. Stimulated kidney tubular epithelial cells express membrane associated and secreted TNF-α. Kidney Int 1991;40:203-11.
45. Wuthrich RP, Glimcher LH, Yui MA, Jevnikar AM, Dumas SE, Kelley VE. MHC class II, antigen presentation and tumor necrosis factor in renal tubular epithelial cells. Kidney Int 1990;37:783-92.
46. Schmouder RL, Strieter RM, Wiggins RC, Chensue SW, Kunkel SL. In vitro and in vivo interleukin-8 production in human renal cortical epithelia. Kidney Int 1992;41:191-8.
47. Brady H. Leukocyte adhesion molecules and kidney diseases. Kidney Int 1994;45:1285-1300.
48. Jevnikar AM, Wuthrich RP, Takei F, Xu H, Brennan DC, Glimcher LH, Rubin-Kelley VE. Differing regulation and function of ICAM-1 and class II antigens on renal tubular cells. Kidney Int 1990;38:417-25.
49. Kelley VR, Diaz-Gallo C, Jevnikar AM, Singer GG. Renal tubular epithelial and T cell interactions in autoimmune renal disease. Kidney Int 1993;43 (39 Suppl):S108-15.
50. Muller GA, Markovic-Lipkovski J, Muller CA. Intracellular adhesion molecule-1 expression in human kidneys with glomerulonephritis. Clin Nephrol 1991;36:203-8.
51. Muller GA, Markovic-Lipkovski J, Rodemann HP. The progression of renal diseases: on the pathogenesis of renal interstitial fibrosis. Klim Wochenschr 1991;69:576-86.
52. Hagerty DT, Allen PM. Processing and presentation of self and foreign antigens by the renal proximal tubule. J Immunol 1992;148:2324-30.
53. Kelly CJ, Roth DA, Meyers CM. Immune recognition and response to the renal interstitium. Kidney Int 1991;31:518-30.
54. Roy-Chaudhury P, Wu B, King G, Campbell M, Macleod AM, Haites NE, Simpson JG, Power DA. Adhesion molecule interactions in human glomerulonephritis importance of the tubulointerstitium. Kidney Int 1996;49:127-34.
55. Haverty TP, Kelly CJ, Hines WH, Amenta PS, Watanabe M, Harper RA, Kefalides NA, Neilson EG. Characterization of a renal tubular epithelial cell line which secretes the autologous target antigen of autoimmune experimental interstitial nephritis. J Cell Biol 1988;107:1359-68.
56. Creely JJ, DiMari SJ, Howe AM, Haralson MA. Effects of transforming growth factor-β on collagen synthesis by normal rat kidney epithelial cells. Am J Pathol 1992;140: 45-55.
57. Burton CJ, Combe C, Walls J, Harris KPG. Fibronectin production by human tubular cells: the effect of apical protein. Kidney Int 1996;50:760-7.
58. Strutz F, Okada H, Lo CW, Danoff T, Carone RL, Tomaszewski JE, Neilson EG. Identification and characterization of a fibroblast marker: FSP1. J Cell Biol 1995;130:393-405.
59. Nadasdy T, Laszik Z, Blick KE, Johnson DL, Silva FG. Tubular atrophy in the end-stage kidney: a lectin and immunohistochemical study. Hum Pathol 1994;25:22-8.
60. Cameron JS, Turner DR, Ogg CS, Chantler C, Williams DG. The long-term prognosis of patients with focal segmental glomerulosclerosis. Clini Nephrol 1978;10:213-8.
61. Erwin DT, Donadio JV Jr, Holley KE. The clinical course of idiopathic membranous nephropathy. Mayo Clin Proc 1973;48:697-712.
62. D'Amico G, Minetti L, Ponticelli C, Fellin G, Ferrario F, Di Belgioioso GB, Imbasciati E, Ragni A, Bertoli S, Fogazzi G, et al. Prognostic indicators in idiopathic IgA mesangial nephropathy. QJM 1986;59:363-378.
63. Radford MG Jr, Donadio JV Jr, Bergstralh EJ, Grande JP. Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol 1997;8:199-207.
64. Cameron JS, Turner DR, Heaton J, Williams DG, Ogg CS, Chantier C, Haycock GB, Hicks J. Idiopathic mesangiocapillary glomerulonephritis. Am J Med 1983;74:175-92.
65. Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, Striker G. The effects of dietary protein restriction and bloodpPressure control on the progression of chronic renal disease. N Engl J Med 1994;330:877-84.
66. Croker BP, Dawson DV, Sanfilippo F. IgA Nephropathy: correlation of clinical and histologic features. Lab Invest 1983;48:19-24.
67. Okada K, Funai M, Kawakami K, Kagami S, Yano I, Kuroda Y. IgA nephropathy in Japanese children and adults: a comparative study of clinicopathological features. Am J Nephrol 1990;10:191-7.
68. Widstam-Attorps U, Berg U, Bohman S, Lefvert A. Proteinuria and renal function in relation to renal morphology. Clin Nephrol 1992;38:245-53.
69. Mauer SM, Steffes MW, Ellis EN, Sutherland DER, Brown DM, Goetz FC. Structural-functional relationships in diabetic nephropathy. J Clin Invest 1984;74:1143-55.
70. Lane PH, Steffes MW, Fioretto P, Mauer SM. Renal interstitial expansion in insulin-dependent diabetes mellitus. Kidney Int 1993;43:661-7.
71. Fogo A, Breyer JA, Smith MC, Cleveland WH, Agadoa L, Kirk KA, Glassock R. Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report From the African American Study of Kidney Disease (AASK) trial. Kidney Int 1997;51:244-52.
72. Appel G. Renal involvement in systemic lupus. Medicine 1978;57:371-410.
73. Magil AB. Tubulointerstitial lesions in human membranous glomerulonephritis: relationship to proteinuria. Amer J Kidney Dis 1995;25:375-9.
74. Honkanen E, Gronhagen-Riska C, von Willerbrand E, Tornroth T, Laasonen L. Renal mononuclear inflammatory cell populations in membranous glomerulonephritis: A fine-needle aspiration biopsy study. Clin Nephrol 1987;28:232-7.
75. Yoshioka K, Takemura T, Murakami K, Okada M, Yagi K, Miyazato H, Matsushima K, Maki S. In situ expression of cytokines in IgA nephritis. Kidney Int 1993;44:825-33.
76. Diamond JR, Anderson S. Irreversible tubulointerstitial damage associated with chronic aminonucleoside nephrosis: amelioration by angiotensin I converting enzyme inhibition. Am J Pathol 1990;137:1323-32.
77. Eddy AA, McCulloch L, Liu E, Adams J. A relationship between proteinuria and acute tubulointerstitial disease in rats with experimental nephrotic syndrome. Am J Pathol 1991;138:1111-23.
78. Eddy AA. Interstitial nephritis induced by protein-overload proteinuria. Am J Pathol 1989;135:719-33.
79. Floege J, Hackmann B, Kliem V, Kriz W, Alpers CE, Johnson RJ, Kuhn KW, Koch K, Brunkhorst R. Age-related glomerulosclerosis and interstitial fibrosis in milan normotensive rats: a podocyte disease. Kidney Int 1997;51:230-43.
80. Olbricht CJ, Cannon JK, Garg LC, Tisher C. Activities of cathepsins B and L in isolated nephron segments from proteinuric and nonproteinuric rats. Am J Physiol 1986;250:F1055-62.
81. Maack T, Johnson V, Kau ST, Figueiredo J, Sigulem D. Renal filtration, transport, and metabolism of low-molecular-weight proteins: a review. Kidney Int 1979;16:251-70.
82. Eddy AA, Ho GC, Thorner PS. The contribution of antibody-mediated cytotoxicity and immune-complex formation to tubulointerstitial disease in passive Heymann nephritis. Clin Immunol Immunopathol 1992;62:42-55.
83. Mendrick DL, Noble B, Brentjens JR, Andres GA. Antibody-mediated injury to proximal tubules in Heymann nephritis. Kidney Int 1980;18:328-43.
84. Brodkin M, Noble B. Antibody-mediated proliferation of proximal tubule cells. Clin Exp Immunol 1988;71:107-12.
85. Remuzzi G, Giuseppe R, Ruggenenti P, Benigni A. Understanding the nature of renal disease progression. Kidney Int 1997;51:2-15.
86. Feld SM, Hirschberg R, Artishevsky A, Nast C, Adler SG. Insulin-like growth factor I induces mesangial proliferation and increases mRNA and secretion of collagen. Kidney Int 1995;48:45-51.
87. Eddy AA. Experimental insights into fhe fubulointerstitial xisease accompanying primary glomerular lesions. J Am Soc Nephrol 1994;5:1273-87.
88. Ehrenreich H, Anderson RW, Fox CH, Rieckmann P, Hoffman GS, Travis WD, Coligan JE, Kehrl JH, Fauci AS. Endothelins, peptides with potent vasoactive properties, are produced by human macrophages. J Exp Med 1990;172:1741-8.
89. Kohan DE. Endothelin synthesis by rabbit renal tubule cells. Am J Physiol 1991;261:F221-6.
90. 1 cells: an intra-and intercellular messenger for activation of soluble guanylate cyclase. J Pharm Exp Therap 1991;256:38-43.
91. Zager RA, Teubner EJ, Adler S. Low molecular weight proteinuria exacerbates experimental ischemic renal injury. Lab Invest 1987;56:180-8.
92. Zager RA. Myoglobin depletes renal adenine nucleotide pools in the presence and absence of shock. Kidney Int 1991;39:111-9.
93. Shoskes DA, Parfrey NA, Halloran PF. Increased major histocompatibility complex antigen expression in unilateral ischemic acute tubular necrosis in the mouse. Transplantation 1990;49:201-7.
94. Shackleton C. Effect of recovery from ischemic injury on class I and class II MHC antigen expression. Transplantation 1990;49:641-4.
95. Fine LG, Norman JT, Ong A. Cell-cell cross talk in the pathogenesis of renal interstitial fibrosis. Kidney Int 1995;47:48-50.
96. Kleinman JG, Worcester EM, Beshensky AM, Sheridan AM, Bonventre JV, Brown D. Upregulation of osteopontin expression by ischemia in rat kidney. Ann NY Acad Sci 1995;760:321-3.
97. Alfrey AC. Role of iron and oxygen radicals in the progression of chronic renal failure. Am J Kidney Dis 1994;23:183-7.
98. Sponsel HT, Alfrey AC, Hammond WS, Durr JA, Ray C, Anderson RJ. Effect of iron on renal tubular epithelial cells. Kidney Int 1996;50:436-44.
99. Nankivell BJ, Boadle RA, Harris DCH. Iron accumulation in human chronic renal disease. Am J Kidney Dis 1992;20:580-4.
100. Alfrey AC, Froment DH, Hammond WS. Role of iron in the tubulo-interstitial injury in nephrotoxic serum nephritis. Kidney Int 1989;36:753-9.
101. Nankivell BJ, Tay Y, Boadle RA, Harris DCH. Dietary protein alters tubular iron accumulation after partial nephrectomy. Kidney Int 1994;45:1006-13.
102. Harris D, Chen J. Monocyte chemoattractant protein-1 (MCP-1) mRNA expression in response to protein in rat proximal tubule cells in culture. J Am Soc Nephrol 1995;6:1015A.
103. Sacks SH, Zhou W, Sheerin NS. Complement synthesis in the injured kidney. does it have a role in immune complex glomerulonephritis? J Am Soc Nephrol 1996;7:2314-19.
104. Halperin JA, Taratuska A, Nicholson-Weller A. Terminal complement complex C5b-9 stimulates mitogenesis in 3T3 cells. J Clin Invest 1993;91:1974-8.
105. Schulze M, Donadio JV, Pruchno CJ, Baker PJ, Johnson RJ, Stahl RAK, Watkins S, Martin DC, Wurzner R, Gotze O, Couser WJ. Elevated urinary excretion of the C5b-9 complex in membranous nephropathy. Kidney Int 1991;40:533-8.
106. Ogrodowski JL, Hebert LA, Sedmak D, Cosio FG, Tamerius J, Kolb W. Measurement of SC5b-9 in urine un patients with the nephrotic syndrome. Kidney Int 1991;40:1141-7.
107. Camussi G, Rotunno M, Segoloni G, Brentjens JR, Andres GA. In vitro alternative pathway activation of complement by the brush border of proximal tubules of normal rat kidney. J Immunol 1982;128:1659-63.
108. Brooimans RA, Stegmann APA, van Dorp WT, van der Ark AAJ, van der Woude FJ, Van es LA, Daha MR. Interleukin 2 mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells. J Clin Invest 1991;88:379-84.
109. Welch TR, Beischel LS, Witte DP. Differential expression of complement C3 and C4 in the human kidney. J Clin Invest 1993;92:1451-8.
110. Welch TR, Beischel LS, Frenzke M, Witte D. Regulated expression of complement factor B in the human kidney. Kidney Int 1996;50:521-5.
111. Zhou W, Andrews PA, Wang Y, Wolff J, Pratt J, Hartley BR, Verroust P, Sacks SH. Evidence for increased synthesis of complement C4 in the renal epithelium of rats with passive Heymann nephritis. J Am Soc Nephrol 1997;8:214-22.
112. 99mTe And urinary ammonia: effects of proteinuria. Miner Electrolyte Metab 1992;18:108-12.
113. Nath KA, Hostetter MK, Hostetter TH. Ammonia-complement interaction in the pathogenesis of progressive renal injury. Kidney Int 1989;36 (27 Suppl):S52-4.
114. Nath KA, Hostetter MK, Hostetter TH. Pathophysiology of chronic tubulo-interstitial disease in rats: interaction of dietary acid load, ammonia, and complement component C3. J Clin Invest 1985;76:667-75.
115. Gharaee-Kermani M, Wiggins R, Wolber F, Goyal M, Phan SH. Fibronectin is the major fibroblast chemoattractant in rabbit antiglomerular basement membrane disease. Am J Pathol 1996;148:961-71.
116. 5 iIntegrin. Kidney Int 1996;50:1310-20.
117. Kohan DE. Endothelins in the normal and diseased kidney. Am J Kid Dis 1997;29:2-26.
118. Keane WF. Lipids and the kidney. Kidney Int 1994;46:910-20.
119. Lee HS, Kim BC, Kim YS, Choi KH, Chung HK. Involvement of oxidation in LDL-induced collagen gene regulation in mesangial cells. Kidney In 1996;50:1582-90.
120. Gomo ZAR, Henderson LO. High-density lipoprotein apolipoproteins in urine: II. enzyme-linked immunoassay of apolipoprotein A-1. Clin Chem 1988;34:1781-6.
121. Grone H, Hohbach J, Grone EF. Modulation of glomerular sclerosis and interstitial fibrosis by native and modified lipoproteins. Kidney Int 1996;49 (54 Suppl):S18-S22.
122. Eddy AA. Expression of genes that promote renal interstitial fibrosis in rats with proteinuria. Kidney Int 1996;49 (54 Suppl):S49-S54.
123. Eddy AA. Interstitial inflammation and fibrosis in rats with dietiInduced hypercholesterolemia. Kidney Int 1996;50:1139-49.
124. El Nahas AM, Muchaneta-Kubara EC, Zhang GZ, Adam A, Goumenos D. Phenotypic modulation of renal cells during experimental and clinical renal scarring. Kidney Int 1996;49 (54 Suppl):S23-7.
125. Diamond JR, van Goor H, Ding G, Engelmyer E. Myofibroblasts in experimental hydronephrosis. Am J Pathol 1995;146:121-9.
126. Alpers CE, Hudkins KL, Floege J, Johnson RJ. Human renal cortical interstitial cells with some features of smooth muscle cells participate in tubulointerstitial and crescentic glomerular injury. JASN 1994;5:201-10.
127. Goumenos DS, Brown CB, Shortland J, El Nahas AM. Myofibroblasts, predictors of progression of mesangial IgA nephropathy? Nephrol Dial Transpl 1994;9:1418-25.
128. Hewitson TD, Becker GJ. Interstitial myofibroblasts In IgA glomerulonephrilis. Am J Nephrol 1995;15:111-7.
129. Pichler RH, Hugo C, Shankland SJ, Reed MJ, Bassuk JA, Andoh TF, Lombardi DM, Schwartz SM, Bennett WM, Alpers CE, Sage EH, Johnson RJ, Couser WG. SPARC is expressed in renal interstitial fibrosis and in renal vascular injury. Kidney Int 1996;50:1978-89.
130. Zhang G, Moorhead PJ, El Nahas AM. Myofibroblasts and the progression of experimental glomerulonephritis. Exp Nephrol 1995;3:308-18.
131. Nouwen EJ, Verstrepen WA, Buyssens N, Zhu M, DeBroe ME. Hyperplasia, hypertrophy, and phenotypic alterations in the distal nephron after acute proximal tubular injury in the rat. Lab Invest 1994;70:479-93.
132. Wiggins R, Goyal M, Merritt S, Killen PD. Vascular adventitial cell expression of collagen I messenger ribonucleic acid in antiglomerular basement membrane sntibody-induced crescentic nephritis in the rabbit. Lab Invest 1993;68:557-65.
133. Alpers CE, Seifert RA, Hudkins KL, Johnson RJ, Bowen-Pope DF. PDGF-receptor localizes to mesangial, parietal epithelial, and interstitial cells in human and primate kidneys. Kidney Int 1993;43:286-94
134. Gesualdo L, Di Paolo S, Miani S, Pinzani M, Grappone C, Ranieri E, Pannarale G, Schena FP. Expression of platelet-derived growth factor receptors in normal and siseased human kidney. J Clin Invest 1994;94:50-8.
135. Fellstrom B, Klareskog L, Heldin CH, Larsson E, Ronnstrand L, Terracio L, Tufveson G, Wahlberg J, Rubin K. Platelet-derived growth factor receptors in the kidney-upregulated expression in inflammation. Kidney Int 1989;36:1099-102.
136. Tang WW, Ulich TR, Lacey DL, Hill DC, Qi M, Kaufman SA, Van GY, Tarpley JE, Yee JS. Platelet-derived growth factor-BB induces renal tubulointerstitial myofibroblast formation and tubulointerstitial fibrosis. Am J Pathol 1996;148:1169-80.
137. Eddy AA. Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 1996;7:2495-508.
138. Border W, Noble N. Transforming growth factor β in tissue fibrosis. N Engl J Med 1994;331:1286-92.
139. Sharma K, Ziyadeh FN. The emerging role of transforming growth factor-β in kidney diseases. Am J Physiol 1994;266:F829-42.
140. Alvarez RJ, Sun MJ, Haverty TP, Iozzo RV, Myers JC, Neilson EG. Biosynthetic and proliferative characteristics of tubulointerstitial fibroblasts probed with paracrine cytokines. Kidney Int 1992;41:14-23.
141. Atkins RC, Nikolic-Paterson DJ, Song Q, Lan HY. Modulators of crescentic glomerulonephritis. JASN 1996;7:2271-8.
142. Palmer BF. Nephrotic edema-pathogenesis and treatment. Am J Medical Sciences 1993;306:53-67.
143. Ghiggeri GM, Ginevri F, Candiano G, Oleggini R, Perfumo F, Queirolo C, Gusmano R. Characterization of cationic albumin in minimal change nephropathy. Kidney Int 1987;32:547-53.
144. Okuda S, Oochi N, Wakisaka M, Kanai H, Tamaki K, Nagase S, Onoyama K, Fujishima M. Albuminuria is not an aggravating factor in experimental focal glomerulosclerosis and hyalinosis. J Lab Clin Med 1992;119:245-53.
145. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993;329:1456-62.
146. Viberti G, Morgenen CE, Groop LC, Pauls JF. Effect of captopril on progression to clinical proteinuria in patients with insulin dependent diabetes mellitus and microalbuminuria. JAMA 1994;271:275-9.
147. Bakris GL, Copley JB, Vicknair N, Sadler R, Leurgans S. Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy. Kidney Int 1996;50:1641-50.
148. Maschio G, Alberti D, Janin G, Locatelli F, Mann JFE, Motolese M, Ponticelli C, Ritz E, Zucchelli P. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 1996;334:939-45.
149. Zeller K, Whittaker E, Sullivan L, Raskin P, Jacobson HR. Effect of restricting dietary protein on the progession of renal failure in patients with insulin-dependent diabetes mellitus. N Engl J Med 1991;324:78-84.
150. Fouque D, Laville M, Boissel JP, Chifflet R, Labeeuw M, Zech PY. Controlled low protein diets in chronic renal insufficiency. Meta-Analysis. Brit Med J 1992;304:216-20.
151. Pedrini MT, Lewey AS, Lau J, Chalmer TC, Wang PH. The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta-analysis. Ann Intern Med 1996;124:627-32.
152. Brenner BM, Lawler EV, Mackenzie HS. The hyperfiltration theory: a paradigm shift in nephrology. Kidney Int 1996;49:1774-7.
153. ter Wee PM, Epstein M. Angiotensin-converting enzyme inhibitors and progression of nondiabetic chronic renal disease. Arch Intern Med 1993;153:1749-59.
154. Kasiske BL, Kalil RSN, Ma JZ, Liao M, Keane WF. Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta regression analysis. Ann Intern Med 1993;118:129-38.
155. Zoja C, Donadelli R, Corna D, Testa D, Facchinetti D, Maffi F, Luzzana E, Colosio V, Bertani T, Remuzzi G. The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotension II: evidence based on comparative studies with a receptor antagonist. Am J Kidney Dis 1997;29:254-64.
156. Giachelli CM, Pichler R, Lombardi D, Denhardt DT, Alpers CE, Schwartz SM, Johnson RJ. Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis. Kidney Int 1994;45:515-24.
157. Egido J. Vasoactive hormones and renal aclerosis. Kidney Int 1996;49:578-97.
158. Wolf G, Mueller E, Stahl RAK, Ziyadeh FN. Angiotensin II-induced hypertrophpy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-β. J Clin Invest 1993;92:1366-72.
159. Rosenberg ME, Smith LJ, Correa-Rotter R, Hostetter TH. The paradox of the renin angiotensin system in chronic renal disease. Kidney Int 1994;45:403-10.
160. Diamond JR. Macrophages and progressive renal disease in experimental hydronephrosis. Am J Kidney Dis 1995;26:133-40.
161. Diamond JR, Kees-Folts D, Ricardo SD, Pruznak A, Eufemio M. Early aAnd persistent up-regulated expression of renal cortical osteopontin in experimental hydronephrosis. Am J Pathol 1995;146:1455-66.
162. Ricardo SD, Levinson ME, DeJoseph MR, Diamond JR. Expression of adhesion molecules in rat renal cortex during experimental hydronephrosis. Kidney Int 1996;50:2002-10.
163. Klahr S, Ishidoya S, Morrissey J. Role of angiotensin II in the tubulointerstitial fibrosis of obstructive nephropathy. Am J Kidney Dis 1995;26:141-6.
164. Ishidoya S, Morrissey J, McCracken R, Klahr S. Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats wtih obstructive nephropathy. Kidney Int 1996;49:1110-9.
165. Pimentel JL Jr, Montero A, Wang S, Yosipiv I, Ell-Dahr S, Martinez-Maldonado M. Sequential changes in renal expression of renin-angiotensin system genes in acute unilateral ureteral obstruction. Kidney Int 1995;48:1247-53.
166. Ruiz-Ortega M, Gonzalez S, Seron D, Condom E, Bustos C, Largo R, Gonnzalez E, Ortiz A, Egido J. ACE inhibition reduces proteinuria, glomerular lesions and extracellular matrix production in a normotensive rat model of immune complex nephritis. Kidney Int 1995;48:1778-91.
167. Diamond JR, Anderson S. Irreversible tubulointerstitial damage associated with chronic aminonucleoside nephrosis. Am J Pathol 1990;137:1323-32.
168. Norman JT, Gallego C, Bridgeman DA, Fogo A, Fine LG. Enalapril ameliorates interstitial fibrosis in the remnant kidney of the rat. J Am Soc Nephrol 1992;3:746.
169. Inserra F, Romano LA, de Cavanagh EMV, Ercole L, Ferder LF, Gomez RA. Renal interstitial sclerosis in aging: effects of enalapril and nifedipine. J Am Soc Nephrol 1996;7:676-80.
170. Bennett WM, DeMattos A, Meyer MM, Andoh T, Barry JM. Chronic cyclosporine nephropathy: the achilles' heel of immunosuppressive therapy. Kidney Int 1996;50:1089-100.
171. Keilani T, Schlueter WA, Levin ML, Batlle DC. Improvement of lipid abnormalities associated with proteinuria using fosinopril, an angiotensin-converting enzyme inhibitor. Ann Intern Med 1993;118:246-54.
172. Fukui M, Nakamura T, Ebihara I, Nagaoka I, Tomino Y, Koide H. Low-protein diet attenuates increased gene expression of platelet-derived growth factor and transforming growth factor-β in experimental glomerular sclerosis. J Lab Clin Med 1993;121:224-34.